Abstract 15490: Immunogenic Verification of MHC-homo iPS Cell-derived Cardiomyocytes Transplantation to an MHC-matched Non-human Primate Ischemic Cardiomyopathy Model: Pre-clinical Study for Allogenic Therapy Using iPS Cells
Noriyuki Kashiyama(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Takuji Kawamura(The University of Osaka), Köichi Toda(The University of Osaka), Satsuki Fukushima(National Cerebral and Cardiovascular Center), Shigeru Miyagawa(The University of Osaka), Toru Kuratani, Shigeo Masuda, Atsuhiro Saito, Ai Kawamura(Max Planck Institute for Heart and Lung Research), Takayoshi Ueno, Shohei Yoshida(Kanazawa University)
Cited by 0
Related Papers
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Development of <i>In Vitro</i> Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells
|Tissue Engineering Part C Methods|2017|103
Are stored carbohydrates necessary for seed production in temperate deciduous trees?
|Journal of Ecology|2012|89
Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat
|International Journal of Oncology|2002|56